Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bloodthinner
Biotech
PhaseBio shows Brilinta reversal agent can work in an emergency
PhaseBio now has the phase 3 data to back up the use of a Brilinta-reversal agent in patients who are in an emergency situation.
Emmy Lucas
Nov 15, 2021 11:31am
PhaseBio's Brilinta reversal agent wins midstage test
Nov 3, 2021 10:16am
PhaseBio taps a manufacturing partner for Brilinta-reversing med
Mar 11, 2021 9:50am
How COVID-19 could be crippled by an age-old blood thinner
Jul 20, 2020 8:30am
